Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services (2)
Select solutions
Active Filters (2)
Clear All
1 - 7 of 7 Results
Sort by:
Best Match
Whitepaper
ImmuSignature™ MLR: Rapid high-throughput assessment of therapeutic immunogenicity
This white paper describes how a rapid immunogenicity assessment screening can provide invaluable support for IND applications.
Whitepaper
Assessing the epigenetics of T cell exhaustion using CRISPR screens
Explore the epigenetics of T cell exhaustion and practical techniques to assess immune cell epigenetic regulators using CRISPR screens.
Application Note
Rapid screening of novel therapeutics by ImmuSignature™ T cell activation assay
This application note describes the development of a robust T cell activation assay to assess the impact of novel therapeutics on T cell function.
Application Note
Optimization of complement-dependent cytotoxicity assay on OncoSignature cell lines
This application note provides insight into how our complement-dependent cytotoxicity assay can help drug screening efforts by leveraging our semi-automated screening platform and OncoSignature™ cell panel.
Guide
Immune cell compound screening compendium
This application compedium provides an overview of four immune cell compound screening applications using ImmuSignature™ assays.
Whitepaper
Redefining the genomics landscape: Navigating the future of personalized medicine
Explore the future of personalized medicine with our comprehensive whitepaper on the evolving genomics landscape and innovative services by Revvity Omics.
Infographic
Uncover the Global Tuberculosis (TB) Landscape
Download our exclusive infographic on the global TB landscape. Explore key insights on diagnostics, prevention, and elimination strategies. Join the fight against TB.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.